We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Artisan Partners
APAM
$2.33B
| $37.3M | 0.67% |
820,355
-8,740
| -1% | -$413K |
2013 Q2
7 quarters
|
|
52
Idexx Laboratories
IDXX
$43.1B
| $37.3M | 0.67% |
482,770
-5,880
| -1% | -$458K |
2014 Q4
1 quarter
|
|
53
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $37M | 0.67% |
751,287
+498,926
| +198% | +$24.8M |
2013 Q2
7 quarters
|
|
|
CONE
54
DELISTED
CyrusOne Inc Common Stock
CONE
| $35.1M | 0.63% |
+1,127,564
| New | +$33.3M |
2015 Q1
0 quarters
|
|
55
Cardinal Health
CAH
$58.7B
| $35.1M | 0.63% |
388,517
+2,715
| +0.7% | +$234K |
2014 Q1
4 quarters
|
|
56
T. Rowe Price
TROW
$21.6B
| $35.1M | 0.63% |
432,906
-6,335
| -1% | -$522K |
2013 Q2
7 quarters
|
|
|
AGN
57
DELISTED
Allergan plc
AGN
| $34.9M | 0.63% |
117,102
+75,222
| +180% | +$21.4M |
2013 Q2
7 quarters
|
|
|
ETP
58
DELISTED
Energy Transfer Partners, L.P.
ETP
| $34.1M | 0.62% |
825,492
+525,851
| +175% | +$22.3M |
2013 Q2
7 quarters
|
|
59
Corpay
CPAY
$26.7B
| $34M | 0.61% |
225,090
-79,597
| -26% | -$11.8M |
2013 Q2
7 quarters
|
|
60
Edwards Lifesciences
EW
$50.8B
| $31.5M | 0.57% |
1,326,672
+1,278,390
| +2,648% | +$28.7M |
2013 Q2
7 quarters
|
|
61
Bristol-Myers Squibb
BMY
$124B
| $30.7M | 0.56% |
475,920
+443,210
| +1,355% | +$27.7M |
2013 Q2
7 quarters
|
|
|
ITC
62
DELISTED
ITC HOLDINGS CORP
ITC
| $30.7M | 0.55% |
819,040
-979,710
| -54% | -$38.9M |
2013 Q2
7 quarters
|
|
63
Gilead Sciences
GILD
$195B
| $29.1M | 0.53% |
296,506
-158,531
| -35% | -$16.1M |
2013 Q2
7 quarters
|
|
64
DELISTED
TD Ameritrade Holding Corp
AMTD
| $29.1M | 0.53% |
+780,176
| New | +$27.7M |
2015 Q1
0 quarters
|
|
65
CVS Health
CVS
$118B
| $28.1M | 0.51% |
271,808
-1,612
| -0.6% | -$163K |
2013 Q2
7 quarters
|
|
66
Becton Dickinson
BDX
$52.8B
| $27.9M | 0.5% |
199,172
+74,509
| +60% | +$10.4M |
2013 Q2
7 quarters
|
|
67
United Parcel Service
UPS
$83.2B
| $27.3M | 0.49% |
281,903
-272,503
| -49% | -$28M |
2013 Q2
7 quarters
|
|
|
POT
68
DELISTED
Potash Corp Of Saskatchewan
POT
| $25.2M | 0.46% |
781,034
-13,781
| -2% | -$485K |
2014 Q1
4 quarters
|
|
69
NXP Semiconductors
NXPI
$58.3B
| $25M | 0.45% |
248,934
+233,592
| +1,523% | +$20.6M |
2014 Q4
1 quarter
|
|
70
Applied Materials
AMAT
$341B
| $24.6M | 0.44% |
1,088,668
+5,988
| +0.6% | +$143K |
2014 Q4
1 quarter
|
|
71
Sherwin-Williams
SHW
$81.8B
| $24.4M | 0.44% |
257,046
-1,842
| -0.7% | -$172K |
2014 Q4
1 quarter
|
|
72
Brookfield Infrastructure Partners
BIP
$17.1B
| $24M | 0.43% |
1,328,055
+1,082,408
| +441% | +$18.9M |
2013 Q2
7 quarters
|
|
|
KSU
73
DELISTED
Kansas City Southern
KSU
| $23.8M | 0.43% |
232,822
-142,156
| -38% | -$16.1M |
2013 Q2
7 quarters
|
|
74
CBRE Group
CBRE
$39.2B
| $23.3M | 0.42% |
600,689
-16,712
| -3% | -$576K |
2014 Q2
3 quarters
|
|
75
Cognizant
CTSH
$29.6B
| $22.8M | 0.41% |
365,879
+3,662
| +1% | +$216K |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.